BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38805470)

  • 1. [Clinical observation of the course of eosinophilic otitis media against the background of biological therapy of chronic polypous rhinosinusitis].
    Fedin AV
    Vestn Otorinolaringol; 2024; 89(2):95-100. PubMed ID: 38805470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic otitis media; state-of-the-art diagnosis and treatment.
    Iino Y
    Auris Nasus Larynx; 2023 Aug; 50(4):479-489. PubMed ID: 36528403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Otitis media with effusion and chronic upper respiratory tract infection in children: a randomized, placebo-controlled clinical study.
    Otten FW; Grote JJ
    Laryngoscope; 1990 Jun; 100(6):627-33. PubMed ID: 1693411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eosinophilic otitis media as a disease with chronic nasal polyposis and bronchial asthma].
    Kosiakov SIa; Gunenkov AV
    Vestn Otorinolaringol; 2013; (5):80-3. PubMed ID: 24600712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Otitis media in severe asthma associated with chronic rhinosinusitis with nasal polyps: a new therapeutic target for biologics.
    Bartier S; Béquignon E; Thibaut de Ménonville C; Verillaud B; Evrard D; Léger M; Papon JF; Coste A; Taillé C
    J Asthma; 2023 Jan; 60(1):139-144. PubMed ID: 35073225
    [No Abstract]   [Full Text] [Related]  

  • 6. Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media.
    Hamada S; Ogino E; Yasuba H
    Allergol Int; 2021 Jul; 70(3):389-391. PubMed ID: 33685801
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood eosinophilia in patients with severe bronchial asthma and chronic polypous rhinosinusitis treated with dupilumab: A review].
    Petukhova AY; Gromov AS; Solovyov RV; Filippova SG; Prokopieva ER
    Ter Arkh; 2024 Apr; 96(3):303-308. PubMed ID: 38713048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete Remission of Severe Eosinophilic Otitis Media With Dupilumab: A Case Report.
    van der Lans RJL; van Spronsen E; Fokkens WJ; Reitsma S
    Laryngoscope; 2021 Dec; 131(12):2649-2651. PubMed ID: 34216146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of the effectiveness of sinuforte used for the combined treatment of rhinosinusitis and exudative otitis media in children].
    Bogomil'skiĭ MR; Garashchenko TI; Denisova OA
    Vestn Otorinolaringol; 2010; (4):74-7. PubMed ID: 21105351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience of biological therapy in severe forms of chronic rhinosinusitis with nasal polyps in the conditions of regional healthcare].
    Larin RA; Mokeeva PP; Grishin AS
    Vestn Otorinolaringol; 2023; 88(2):51-58. PubMed ID: 37184555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis.
    Nakashima D; Nakayama T; Minagawa S; Adachi T; Mitsuyama C; Shida Y; Nakajima T; Haruna SI; Matsuwaki Y
    Allergol Int; 2023 Oct; 72(4):557-563. PubMed ID: 37061391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic Otitis Media: Modern Aspects of Pathogenesis, Clinical Features, Diagnosis and Treatment.
    Shevchik E; Svistushkin V; Nikiforova G; Zolotova A
    Indian J Otolaryngol Head Neck Surg; 2022 Aug; 74(Suppl 1):132-140. PubMed ID: 36032916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intractable otitis media - Pathogenesis and treatment of Eosinophilic otitis media (EOM) and otitis media with Antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (OMAAV).
    Yoshida N
    Auris Nasus Larynx; 2023 Apr; 50(2):171-179. PubMed ID: 35934599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eosinophilic chronic rhinosinusitis and eosinophilic otitis media].
    Ishitoya J; Sakuma Y
    Arerugi; 2011 May; 60(5):535-45. PubMed ID: 21617355
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease.
    Iino Y; Tomioka-Matsutani S; Matsubara A; Nakagawa T; Nonaka M
    Auris Nasus Larynx; 2011 Aug; 38(4):456-61. PubMed ID: 21251776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL13 May Play an Important Role in Developing Eosinophilic Chronic Rhinosinusitis and Eosinophilic Otitis Media with Severe Asthma.
    Shimizu H; Hayashi M; Kato H; Nakagawa M; Imaizumi K; Okazawa M
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Theories of the pathogenesis of polypous rhinosinusitis and the asthmatic triad].
    Lazareva AM; Kolenchukova OA; Smirnova SV
    Vestn Otorinolaringol; 2023; 88(6):73-80. PubMed ID: 38153897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic Mucin Otomastoiditis and Otopolyposis: A Progressive Form of Eosinophilic Otitis Media.
    Azadarmaki R; Westra W; Prasad S
    Ann Otol Rhinol Laryngol; 2015 Sep; 124(9):752-6. PubMed ID: 25770133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polypous rhinosinusitis in the context of the asthma triad].
    Tsyvkina AA; Tsarev SV
    Vestn Otorinolaringol; 2011; (1):77-80. PubMed ID: 21378746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.